• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Pain Therapeutics Inc

+ Add to Watchlist

PTIE:US

4.5000 USD 0.1300 2.81%

As of 20:10:00 ET on 07/28/2014.

Snapshot for Pain Therapeutics Inc (PTIE)

Open: 4.6500 Day's Range: 4.2600 - 4.7400 Volume: 324,134
Previous Close: 4.6300 52wk Range: 2.1600 - 6.2200 1-Yr Rtn: +71.76%

Stock Chart for PTIE

No chart data available.
  • PTIE:US 4.5000
  • 1D
  • 1M
  • 1Y
4.6300
Interactive PTIE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PTIE

Current P/E Ratio (ttm) 7.3770
Estimated P/E(12/2014) -
Relative P/E vs. SPX 0.4074
Earnings Per Share (USD) (ttm) 0.6100
Est. EPS (USD) (12/2014) -0.3000
Est. PEG Ratio -
Market Cap (M USD) 205.23
Shares Outstanding (M) 45.61
30 Day Average Volume 412,993
Price/Book (mrq) 4.4906
Price/Sale (ttm) 5.1773
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.7500
Dividend Ex-Date 12/13/2012
5 Year Dividend Growth -
Next Earnings Announcement 08/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PTIE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PTIE

Pain Therapeutics, Inc. develops drugs using it proprietary technology. The Company develops safer or more efficacious drugs for use in pain management, particularly in the area of opioid painkillers. Pain Therapeutics has products in clinical trials.

Remi BarbierChairman/President/CEONadav FriedmannCOO/Chief Medical Officer
Grant L SchoenhardChief Scientific OfficerPeter S RoddyVP/CFO
More Company Profile & Key Executives for PTIE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil